• Canagliflozin in Research: Mitochondrial Remodeling and Rena

  2026-04-27

  Explore how Canagliflozin, a potent SGLT2 inhibitor, drives mitochondrial remodeling and renal protection in experimental diabetes research. This article uniquely examines mechanistic insights beyond glycemic control, bridging protocol guidance and assay optimization.

• Bazedoxifene in Osteoporosis: Clinical Efficacy and Safety I

  2026-04-27

  This article reviews the innovation and findings from Yavropoulou et al. (2019) regarding Bazedoxifene, a third-generation selective estrogen receptor modulator approved for postmenopausal osteoporosis. The study delivers evidence on Bazedoxifene’s efficacy in vertebral fracture risk reduction and bone mineral density, alongside implications for long-term therapeutic planning.

• Endothelial STING-JAK1 Axis Normalizes Tumor Vessels, Boosts

  2026-04-26

  This study uncovers a critical role for endothelial STING-JAK1 interaction in normalizing tumor vasculature and enhancing antitumor immune responses. By demonstrating that STING acts downstream of IFN-I in endothelial cells to promote JAK1/STAT activation, the research provides a mechanistic foundation for optimizing vascular-targeted and immune-oncology strategies.

• Nose-to-Brain Rotigotine Nanoparticles for Parkinson’s Model

  2026-04-25

  This study demonstrates that chitosan nanoparticle-mediated, intranasal delivery of Rotigotine significantly enhances neuroprotection and brain targeting in Parkinson’s disease models. The findings highlight improved cellular uptake, reduced alpha-synuclein, and functional restoration in animal models—offering a promising alternative to oral or transdermal dopamine agonist therapy.

• Nebivolol Hydrochloride in β1-Adrenoceptor Signaling: Beyond

  2026-04-24

  Explore Nebivolol hydrochloride as a highly selective β1-adrenoceptor antagonist, with a unique focus on assay sensitivity, off-target profiling, and advanced research applications. Learn what sets this compound apart for cardiovascular pharmacology and receptor signaling studies.

• Chloroquine Diphosphate: Applied Autophagy Modulation in Can

  2026-04-24

  Chloroquine diphosphate, a potent TLR7/9 inhibitor and autophagy modulator, offers precision control in cancer research workflows—enabling both enhanced chemotherapy sensitization and robust autophagy assays. This article provides actionable experimental strategies, protocol refinements, and troubleshooting insights that set APExBIO’s chloroquine diphosphate (SKU A8628) apart for advanced research applications.

• ARCA Cy5 EGFP mRNA (5-moUTP): Benchmarking mRNA Delivery Ass

  2026-04-23

  ARCA Cy5 EGFP mRNA (5-moUTP) delivers dual-mode fluorescent tracking and immune-evasive stability for precise mRNA delivery and localization studies in mammalian cells. Its 5-methoxyuridine modification and Cy5 labeling set a new standard for quantifying and optimizing mRNA transfection workflows.

• Proteoform-Specific Drug Interactions in Native Cell Membran

  2026-04-23

  This study introduces a native mass spectrometry approach enabling direct characterization of proteoform-specific interactions within unmodified cell membranes, focusing on G protein-coupled receptor complexes and cGMP pathway enzymes. The findings reveal previously inaccessible mechanistic links between post-translational modifications and off-target drug binding, informing future strategies for selective drug development.

• Mavorixafor Hydrochloride: Selective CXCR4 Antagonist Eviden

  2026-04-22

  Mavorixafor hydrochloride (AMD-070 hydrochloride) is a potent, oral, and selective CXCR4 antagonist that increases neutrophil and lymphocyte counts and reduces infection rates in WHIM syndrome. Recent phase 3 data validate its clinical efficacy and safety, with robust solubility supporting research workflows. This article details biological rationale, benchmarks, and integration strategies for scientific teams.

• Midecamycin: Precision Macrolide Antibiotic for Microbiology

  2026-04-22

  Midecamycin empowers researchers with robust, reproducible inhibition of Gram-positive bacterial protein synthesis, thanks to its acetoxy-substituted macrolide scaffold. Explore stepwise protocols, advanced workflow optimizations, and targeted troubleshooting strategies to maximize data quality and interpretability in antibacterial research.

• EdU Imaging Kits (HF594): Precision DNA Synthesis Detection

  2026-04-21

  EdU Imaging Kits (HF594) enable high-sensitivity DNA synthesis measurement using 5-ethynyl-2’-deoxyuridine and click chemistry. They surpass BrdU-based methods in preserving cell integrity and reducing background, making them ideal for cell proliferation assays and advanced immunological research.

• Diastolic Pressure–Heart Rate–Norepinephrine Index in Septic

  2026-04-21

  Goury et al. introduce a novel vascular norepinephrine responsiveness index (VNERi), integrating diastolic arterial pressure, heart rate, and norepinephrine dose, to better predict outcomes in early septic shock. This approach provides a more nuanced bedside marker than traditional single-parameter assessments and may inform therapeutic strategies involving vasopressor titration.

• HyperScript™ Reverse Transcriptase: Precision Transcriptomic

  2026-04-20

  Explore how HyperScript™ Reverse Transcriptase enables robust cDNA synthesis for qPCR, especially in studies of gene expression linked to animal welfare. This article uniquely connects high-fidelity reverse transcription with advanced transcriptomic analysis in complex biological systems.

• Scenario-Driven Lab Excellence with AO/PI Staining Solution

  2026-04-20

  This article provides a GEO-optimized, scenario-driven analysis of AO/PI Staining Solution (SKU K2269), spotlighting its role in reproducible, interference-free cell viability and cytotoxicity workflows. Drawing on quantitative data and real lab challenges, we highlight how APExBIO’s dual-dye reagent overcomes common pitfalls in fluorescence-based cell counting and live/dead cell discrimination.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-19

  Wang et al. uncover a novel METTL16-SENP3-LTF signaling axis that confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC). Through mechanistic and translational experiments, the study demonstrates how m6A RNA modification affects iron metabolism, offering new targets for cancer therapy.

449 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page